News - Sandoz, Research

Filter

Current filters:

SandozResearch

Popular Filters

Sandoz initiates Ph III trial for biosimilar Enbrel

24-06-2013

Swiss drug major Novartis' (NOVN: VX) generics unit Sandoz has initiated a major Phase III clinical trial…

AmgenAnti-Arthritics/RheumaticsBiotechnologyDermatologicalsEnbrelGenericsNovartisResearchSandoz

Sandoz to emphasize need for consistent regulatory standards across all biologics at FDA hearings

10-05-2012

Germany-based Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX) announced that Mark McCamish,…

BiotechnologyGeneralNorth AmericaNovartisRegulationResearchSandoz

Sandoz initiates two more Phase III biosimilar trials

20-01-2012

Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX), says that it has initiated two milestone…

AmgenBiotechnologyFilgrastimGenericsNovartisOncologypegfilgrastimResearchSandozZarzio

Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello allergy immunotherapy

05-08-2011

There was another boost for UK inhalation product developer Vectura (LSE: VEC), which announced this…

ALK AbelloGenericsLicensingMerck & CoNovartisPharmaceuticalResearchRespiratory and PulmonarySandozVectura

Back to top